Phase I trial of zirconium 89 (Zr89) radiolabeled J591 in metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract


Authors: Morris, M. J.; Pandit-Taskar, N.; Carrasquillo, J. A.; O'Donoghue, J. A.; Humm, J.; Lyashchenko, S. K.; Haupt, E. C.; Bander, N. H.; Tagawa, S. T.; Holland, J. P.; Smith-Jones, P. M.; Lewis, J. S.; Solomon, S. B.; Scher, H. I.; Larson, S. M.
Abstract Title: Phase I trial of zirconium 89 (Zr89) radiolabeled J591 in metastatic castration-resistant prostate cancer (mCRPC)
Meeting Title: 2013 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 6 Suppl.
Meeting Dates: 2013 Feb 14-16
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-02-20
Language: English
ACCESSION: WOS:000333679600034
DOI: 10.1200/jco.2013.31.6_suppl.31
PROVIDER: wos
Notes: Meeting Abstract: 31 -- Source: Wos
Altmetric Score
MSK Authors
  1. Michael Morris
    274 Morris
  2. Jason Philip Holland
    30 Holland
  3. Stephen Solomon
    266 Solomon
  4. John Laurence Humm
    339 Humm
  5. Jason S Lewis
    242 Lewis
  6. Steven M Larson
    764 Larson
  7. Howard Scher
    817 Scher
  8. Eric C Haupt
    5 Haupt
Related MSK Work